Short antibiotic courses ‘safer’
Baltimore, May 7, 2011
Short courses of antibiotics appear just as effective as longer ones – and a great deal safer – in treating respiratory infections that might cause pneumonia in children on temporary breathing devices, said a report.
A study by Johns Hopkins Children’s Center, an acute care hospital in the US state of Maryland, analysed of 150 children treated with antibiotics for respiratory infections while on a ventilator.
It found longer antibiotic courses did not only fail to confer extra protection against full-blown pneumonia when compared with shorter therapy, but also considerably increased a child’s risk for developing drug-resistant infections within a month.
To rein in the spread of bacterial drug resistance, the researchers advise clinicians to carefully evaluate the need for antibiotics in the first place and to use antibiotics for the shortest time needed to achieve clinical effect.
“Our study underscores the old physician maxim to first do no harm,” said lead investigator Pranita Tamma, MD, an infectious disease specialist at Hopkins Children’s. “Longer treatment is not always more effective, and it could be downright dangerous.”
Children on ventilators often develop respiratory infections, or tracheitis, because the breathing tubes allow bacteria an easy entry into the respiratory tract. These children need antibiotics promptly to prevent the infection from spreading into the lungs, but the optimal length of treatment has been unclear.
“We hope that our findings will help clear up some of the confusion and discourage physicians from preemptively opting for longer treatments,” Tamma said.
The Johns Hopkins investigators analysed three years worth of medical records involving more than 1,600 children, age 18 and younger, who spent at least two days on a breathing tube. Of them, 150 got antibiotics for ventilator-related upper respiratory infections, however only 118 of them met clinical criteria for such infections, and 32 were treated merely on suspicion of infection.
Of the 82 children with actual infections who were treated with antibiotics for more than a week, 23 percent developed pneumonia, compared to 20 percent of the 36 children who got antibiotics for seven days or fewer.
However, children who received the lengthy antibiotic course were five times more likely, on average, to develop drug-resistant infections following the treatment. Children who got multiple antibiotics were three times as likely to do so.
Although the length of antibiotic use made no statistical difference in pneumonia risk, the length of intubation did. Children whose tubes were left in after diagnosis of infection and start of therapy were four times more likely to progress to pneumonia than children taken off the ventilator promptly after diagnosis and start of treatment, the researchers found.
The finding emphasizes the need for careful daily reassessment of each child’s need to stay on a ventilator, they added.
Past research has shown that more than one-third of antibiotic prescriptions for upper respiratory infections in the intensive care unit may be unwarranted, the investigators noted.
“Beyond fueling drug resistance, antibiotics can cause serious side effects and add to healthcare costs. We, as physicians, should ask ourselves two critical questions any time we prescribe them: Does this patient really need antibiotics?” said senior investigator Sara Cosgrove, M.D., an infectious disease specialist at Hopkins.
“If so, ‘what is the shortest course of treatment that will achieve clinical benefit?’” she added. – TradeArabia News Service
More Health & Environment Stories
- Qatar to set up $99bn health, education fund
- Call for major diabetes awareness drive
- WHO to help Saudi probe SARS virus before haj
- WHO warns countries not to hoard virus secrets
- Saudi confirms another death from new virus
- Men ‘at more risk from SARS-like virus’
- Wild poliovirus in the Horn of Africa
- Conference to be held at Burjeel hospital
- Tunisia confirms 2 cases of SARS-like virus
- Bahrain sets up team to combat new virus